Oddity Tech

ODD · NASDAQ

$22.65−$0.70 (−3.00%)TodayMarket closed · Oct 23, 7:53 PM ET

Prev close $23.35

ODD analyst rating

HoldConsensus of 10 analysts over the last 12 months. 0% rate it a buy.

Strong buy0
Buy0
Hold8
Underperform1
Sell1

12-month price target · 9 analysts

Average $16.10 (−28.9% downside)

Low: $9.09
Now: $22.65
High: $23.10

Upgrades and downgrades

The latest rating actions, newest first

ODD analyst upgrades, downgrades and rating actions
Firm	Date	Action	Rating	Price target	Hit rate
Morgan Stanley	Oct 15, 2026	Maintains	Equal-Weight	$16.50 → $18.50	67%
JP Morgan	Sep 21, 2026	Initiates	Neutral	$18.00	27%
Morgan Stanley	Sep 10, 2026	Maintains	Equal-Weight	$10.00 → $16.50	67%
Truist Securities	Sep 10, 2026	Maintains	Hold	$16.00 → $18.00	64%
Evercore ISI Group	Sep 10, 2026	Maintains	In-Line	$15.00 → $21.00	61%
Jefferies	Sep 9, 2026	Maintains	Hold	$16.00 → $18.00	62%
Needham	Sep 8, 2026	Maintains	Hold	—	46%
Truist Securities	Sep 1, 2026	Maintains	Hold	$12.00 → $16.00	64%
Evercore ISI Group	Jun 4, 2026	Maintains	In-Line	$23.00 → $15.00	61%
Morgan Stanley	Jun 3, 2026	Maintains	Equal-Weight	$16.00 → $10.00	67%

The case for and against

Updated Oct 22, 2026

Bull case

ODDITY Tech is supported by a resilient underlying brand portfolio and a business model that continues to show attractive unit economics even amid a temporary CPA disruption. Management’s 25%-30% revenue decline outlook for 2Q26 and $8mm-$10mm adjusted EBITDA guidance point to near-term pressure, but the 28% sequential improvement in IL MAKIAGE CPA in May suggests acquisition efficiency is beginning to normalize, while repeat purchasing remains resilient. Beyond the core turnaround, METHODIQ is off to a strong start with $25M expected revenue this year, and ODD Labs’ new molecules and cost actions provide additional growth and margin support as investors look toward positive Adjusted EBITDA for FY26.

Bear case

ODDITY Tech is viewed negatively because a sudden algorithm change at a major ad partner more than doubled customer acquisition costs, pushed ads into lower-quality auctions, and drove 1Q26 net revenues down 26% year over year to $197.9 million while adjusted EBITDA fell to $(7.0) million. Management still expects FY26 adjusted EBITDA to be positive, but it gave no top-line guidance and 2Q26 revenue is expected to fall 25% to 30% year over year with EBITDA of only $8 million to $10 million, underscoring weak visibility into recovery timing. With 98% of revenue coming from Online DTC and first orders down 50% year over year, the business remains highly exposed to advertising efficiency and repeat-purchase weakness, limiting confidence in a sustained rebound.

Information on this page is provided for informational purposes only and is not a recommendation to buy, sell or hold any security. Investing involves risk, including possible loss of principal. Market data is delayed at least 15 minutes and is provided without warranty. Analyst ratings, price targets and company data come from third-party sources. Past performance does not guarantee future results.